Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy

Details for Australian Patent Application No. 2001264696 (hide)

Owner Genentech, Inc.

Inventors Mass, Robert D.

Agent Griffith Hack

Pub. Number AU-B-2001264696

PCT Pub. Number WO01/89566

Priority 60205754 19.05.00 US

Filing date 18 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 4 January 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

4 January 2007 Application Accepted

  Published as AU-B-2001264696

17 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001264697

2001264695-STORAGE-RETRIEVAL OF PAPER AND ELECTRONIC DOCUMENTS